GGrantIndex
Sort

50,496 grants matching lung cancer

Project 3

$387,707
Pasi A Janne · Dana-Farber Cancer Inst · P50 · FY2024 · CA

Prostate Cancer Recovery Enhancement (PROCARE) for African American Men

$387,697
Lisa C Campbell · East Carolina University · R01 · FY2009 · CA

Immune Regulation of Lung Squamous Metastasis

$387,674
Chad V Pecot · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA

Clinical Investigation of Signal Transduction Inhibitors

$387,610
Phillip A. Dennis · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Early Detection of Changes in Pulmonary Gas Exchange by Hyperpolarized Xe MRI

$387,556
Bastiaan Driehuys · Duke University · R01 · FY2011 · HL

Molecular Biology of the Metastatic Phenotype

$387,540
Patricia Schriver Steeg · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA

Project 3: Carbon and Electron FLASH radiotherapy for mitigation of normal lung injury in NSCLC

$387,534
Amir Abdollahi · University Of Pennsylvania · P01 · FY2023 · CA

Mortality and Renal Disease in a Cohort Study of Lead-Exposed Workers in a Survei

$387,500
Nelson K Steenland · Emory University · R01 · FY2009 · OH

Stinging the Glioma Immune Landscape

$387,468
Amy Beth Heimberger · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · NS

Clinical Diagnostic Studies and Treatment of Patients with Immune Deficiencies

$387,461
Suk De Ravin · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI

Early Detection of Changes in Pulmonary Gas Exchange by Hyperpolarized Xe MRI

$387,461
Bastiaan Driehuys · Duke University · R01 · FY2012 · HL

TAS::75 0872::TAS LUNG TISSUE RESEARCH CONSORTIUM CLINICAL CENTER

$387,456
Andrew H Limper · Mayo Clinic Rochester · N01 · FY2013 · HL

Southwest Oncology Group/ University of California,

$387,416
University Of California Davis · U10 · FY2005 · CA

Epigenetic Control of SMC Transitions to a Multi-Potential Stem Cell-Like State

$387,320
Gary K Owens · University Of Virginia · R01 · FY2013 · HL

ATP-Dependent Chromatin Remodeling in Human Malignancy

$387,313
Gerald R. Crabtree · Stanford University · R01 · FY2023 · CA

Lung Epithelial-Mesenchymal Interactions in Adenocarcinoma Invasion

$387,302
Charles A. Powell · Columbia University Health Sciences · R01 · FY2007 · CA

Mechanism and therapy for arteriovenous malformation

$387,254
S Paul Oh · University Of Florida · R01 · FY2012 · HL

DNA damaging therapy and immune response in small cell lung cancer subtypes

$387,250
Lauren Averett Byers · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA

DNA damaging therapy and immune response in small cell lung cancer subtypes

$387,250
Lauren Averett Byers · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA

Multifunctional PEG Hydrogel Nano/Microparticles for Targeted Treatment of NSCLC

$387,246
Patrick J. Sinko · Rutgers, The State Univ Of N.J. · R01 · FY2011 · CA

Role of the SWI/SNF complex in tumor suppression

$387,236
Charles W Roberts · St. Jude Children'S Research Hospital · R01 · FY2019 · CA

Prospective Studies of Diet and Cancer in the AARP Cohort

$387,195
Rashmi Sinha · Division Of Cancer Epidemiology And Genetics · ZIA · FY2024 · CA

Mechanisms of Parp inhibitor-induced bone marrow toxicities

$387,195
Jane Ellen Churpek · University Of Wisconsin-Madison · R01 · FY2025 · HL

A Rapid and Comprehensive Approach for Clinical Genomic Profiling in Lung Cancer

$387,195
Eric J Duncavage · Washington University · R33 · FY2025 · CA

Optimal Pairing of Chemotherapy with Immunotherapy for Pancreatic Cancer

$387,183
Peter A Cohen · Mayo Clinic Rochester · P50 · FY2017 · CA